AU697610B2 - 4-aminotetrahydrobenzisoxazole or -isothiazole compounds - Google Patents

4-aminotetrahydrobenzisoxazole or -isothiazole compounds

Info

Publication number
AU697610B2
AU697610B2 AU47131/96A AU4713196A AU697610B2 AU 697610 B2 AU697610 B2 AU 697610B2 AU 47131/96 A AU47131/96 A AU 47131/96A AU 4713196 A AU4713196 A AU 4713196A AU 697610 B2 AU697610 B2 AU 697610B2
Authority
AU
Australia
Prior art keywords
group
hydrogen
compound
lower alkyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU47131/96A
Other languages
English (en)
Other versions
AU4713196A (en
Inventor
Erik Falch
Bente Frolund
Povl Krogsgaard-Larsen
Lenz Sibylle Moltzen
Jens Kristian Perregaard
Arne Schousboe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Publication of AU4713196A publication Critical patent/AU4713196A/en
Application granted granted Critical
Publication of AU697610B2 publication Critical patent/AU697610B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nozzles (AREA)
AU47131/96A 1995-02-28 1996-02-28 4-aminotetrahydrobenzisoxazole or -isothiazole compounds Ceased AU697610B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK20795 1995-02-28
DK0207/95 1995-02-28
PCT/DK1996/000084 WO1996026929A1 (en) 1995-02-28 1996-02-28 4-aminotetrahydrobenzisoxazole or -isothiazole compounds

Publications (2)

Publication Number Publication Date
AU4713196A AU4713196A (en) 1996-09-18
AU697610B2 true AU697610B2 (en) 1998-10-15

Family

ID=8090951

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47131/96A Ceased AU697610B2 (en) 1995-02-28 1996-02-28 4-aminotetrahydrobenzisoxazole or -isothiazole compounds

Country Status (30)

Country Link
US (2) US5998613A (cs)
EP (1) EP0812318B1 (cs)
JP (1) JPH11501016A (cs)
KR (1) KR100242675B1 (cs)
CN (1) CN1087290C (cs)
AT (1) ATE317391T1 (cs)
AU (1) AU697610B2 (cs)
BG (1) BG63258B1 (cs)
BR (1) BR9607443A (cs)
CA (1) CA2213127A1 (cs)
CZ (1) CZ290837B6 (cs)
DE (1) DE69635798T2 (cs)
DK (1) DK0812318T3 (cs)
EA (1) EA000380B1 (cs)
EE (1) EE03483B1 (cs)
ES (1) ES2253748T3 (cs)
FI (1) FI973519L (cs)
HU (1) HUP9800631A3 (cs)
IL (1) IL117295A (cs)
IS (1) IS2352B (cs)
NO (1) NO309474B1 (cs)
NZ (1) NZ301653A (cs)
PL (1) PL187404B1 (cs)
RO (1) RO119545B1 (cs)
SI (1) SI0812318T1 (cs)
SK (1) SK281879B6 (cs)
TR (1) TR199700873T1 (cs)
UA (1) UA43396C2 (cs)
WO (1) WO1996026929A1 (cs)
ZA (1) ZA961591B (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998003167A1 (en) 1996-07-24 1998-01-29 Warner-Lambert Company Isobutylgaba and its derivatives for the treatment of pain
GB9622370D0 (en) * 1996-10-28 1997-01-08 Merck Sharp & Dohme Therapeutic agents
US20030185754A1 (en) * 2001-01-16 2003-10-02 Genset, S.A. Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
US20030166554A1 (en) * 2001-01-16 2003-09-04 Genset, S.A. Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
US7378426B2 (en) * 2004-03-01 2008-05-27 Bristol-Myers Squibb Company Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
US7417040B2 (en) * 2004-03-01 2008-08-26 Bristol-Myers Squibb Company Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
KR101354335B1 (ko) * 2009-05-05 2014-02-19 에프. 호프만-라 로슈 아게 인지 장애의 치료에 사용되는 gaba a 수용체 역 작용제로서의 아이속사졸-티아졸 유도체
CA2766033C (en) * 2009-06-25 2016-09-20 Alkermes, Inc. Prodrugs of nh-acidic compounds
CN105758807B (zh) * 2016-02-22 2019-01-29 山东出入境检验检疫局检验检疫技术中心 一种鉴别废润滑油的方法
CN112423754A (zh) 2018-03-05 2021-02-26 奥克梅斯制药爱尔兰有限公司 阿立哌唑的给药策略

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2602643C2 (de) * 1976-01-24 1984-12-20 Bayer Ag, 5090 Leverkusen 1,2-Benzisothiazolinone-3, Verfahren zu ihrer Herstellung sowie Arzneimittel
US4411901A (en) * 1981-12-23 1983-10-25 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4514414A (en) * 1982-10-25 1985-04-30 Smithkline Beckman Corporation N-Substituted pyrrolidineacetic acids and their esters
US4804663A (en) 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
IE60267B1 (en) * 1986-12-26 1994-06-29 Sankyo Co Centrally-acting muscle relaxants
US5321037A (en) * 1986-12-26 1994-06-14 Sankyo Company, Limited Isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants
US5225412A (en) * 1991-04-29 1993-07-06 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides
US5143923B1 (en) * 1991-04-29 1993-11-02 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides

Also Published As

Publication number Publication date
CZ271197A3 (cs) 1998-03-18
SK115197A3 (en) 1998-02-04
EP0812318A1 (en) 1997-12-17
US6174909B1 (en) 2001-01-16
NO973948D0 (no) 1997-08-27
JPH11501016A (ja) 1999-01-26
CN1176638A (zh) 1998-03-18
TR199700873T1 (xx) 1998-01-21
WO1996026929A1 (en) 1996-09-06
PL321956A1 (en) 1998-01-05
RO119545B1 (ro) 2004-12-30
PL187404B1 (pl) 2004-07-30
KR19980702546A (ko) 1998-07-15
EP0812318B1 (en) 2006-02-08
BG63258B1 (bg) 2001-07-31
CA2213127A1 (en) 1996-09-06
AU4713196A (en) 1996-09-18
FI973519A7 (fi) 1997-08-27
BR9607443A (pt) 1998-05-26
KR100242675B1 (ko) 2000-03-02
NZ301653A (en) 1998-12-23
BG101894A (bg) 1998-05-29
DE69635798T2 (de) 2006-08-17
FI973519A0 (fi) 1997-08-27
HK1008527A1 (en) 1999-07-30
IS2352B (is) 2008-04-15
CN1087290C (zh) 2002-07-10
HUP9800631A2 (hu) 1998-08-28
EE03483B1 (et) 2001-08-15
DK0812318T3 (da) 2006-06-06
SK281879B6 (sk) 2001-08-06
IL117295A0 (en) 1996-06-18
NO973948L (no) 1997-08-27
CZ290837B6 (cs) 2002-10-16
FI973519L (fi) 1997-08-27
IL117295A (en) 1999-11-30
ATE317391T1 (de) 2006-02-15
ES2253748T3 (es) 2006-06-01
EA000380B1 (ru) 1999-06-24
ZA961591B (en) 1996-08-28
DE69635798D1 (de) 2006-04-20
UA43396C2 (uk) 2001-12-17
HUP9800631A3 (en) 1998-12-28
IS4542A (is) 1997-08-13
EA199700199A1 (ru) 1998-02-26
US5998613A (en) 1999-12-07
SI0812318T1 (sl) 2006-06-30
EE9700197A (et) 1998-02-16
MX9706280A (es) 1998-06-30
NO309474B1 (no) 2001-02-05

Similar Documents

Publication Publication Date Title
KR840002427B1 (ko) 모르폴린 유도체의 제조방법
JPH09509155A (ja) プロテアーゼインヒビター
AU697610B2 (en) 4-aminotetrahydrobenzisoxazole or -isothiazole compounds
SK279058B6 (sk) Substituovaný n-[(2-morfolynyl)alkyl]banzamidový d
JP2009513697A (ja) ヒストンデアセチラーゼの阻害活性を有するアルキルカルバモイルナフタレニルオキシオクテノイルヒドロキシアミド誘導体およびその製造方法
EP0125056B1 (en) Condensed, seven-membered ring compounds, their production and use
FR2674849A1 (fr) Nouveaux derives de n-cyclohexyl benzamides ou thiobenzamides, leurs preparations et leurs applications en therapeutique.
IE61811B1 (en) 2-amino-7-hydroxytetralin carboxyalkyl ethers
KR20070046879A (ko) 5-ht7 수용체 안타고니스트
EP1399419A1 (en) New compounds useful in reflux disease
AU2002309420A1 (en) New compounds useful in reflux disease
KR20070046878A (ko) 5-ht7 수용체 안타고니스트
WO2004011457A1 (en) 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof
MXPA97006280A (en) Compounds 4-aminotetrahidrobenzisoxasol oisotia
DE69615696T2 (de) Heterocyclische verbindungen zur behandlung von myokard-ischemia
NO323263B1 (no) Heterosyklisk derivat, fremgangsmater for dets fremstilling, farmasoytiske sammensetninger som inneholder dette, anvendelse av dette for fremstilling av et preparat for medisinsk bruk samt nevnte derivat til bruk som medikament
CS212736B2 (en) Method of preparing 3h-pyrido-/3,2-e/-1,4-diazepines
CN118930552A (zh) 异苯并呋喃-1(3h)-酮类化合物及其制备方法、药物组合物和用途
IE880244L (en) Pilocarpine derivatives
KR20070098882A (ko) 5-ht7 수용체 안타고니스트
JP2000239274A (ja) 新規ナフチリジン誘導体の製造法
JPS63115858A (ja) 医薬組成物